Enzyme-Instructed Self-assembly in Biological Milieu for Theranostics Purpose

Curr Med Chem. 2019;26(8):1351-1365. doi: 10.2174/0929867324666170921104010.

Abstract

Precision medicine is in an urgent need for public healthcare. Among the past several decades, the flourishing development in nanotechnology significantly advances the realization of precision nanomedicine. Comparing to well-documented nanoparticlebased strategy, in this review, we focus on the strategy using enzyme instructed selfassembly (EISA) in biological milieu for theranostics purpose. In principle, the design of small molecules for EISA requires two aspects: (1) the substrate of enzyme of interest; and (2) self-assembly potency after enzymatic conversion. This strategy has shown its irreplaceable advantages in nanomedicne, specifically for cancer treatments and Vaccine Adjuvants. Interestingly, all the reported examples rely on only one kind of enzymehydrolase. Therefore, we envision that the application of EISA strategy just begins and will lead to a new paradigm in nanomedicine.

Keywords: Enzyme; Nanotechnology; Precision medicine; Self-assembly; Theranostics; Vaccine adjuvants..

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic / chemistry
  • Adjuvants, Immunologic / metabolism
  • Adjuvants, Immunologic / therapeutic use
  • Animals
  • Biocatalysis
  • Dimerization
  • Humans
  • Hydrogels / chemistry
  • Hydrogels / metabolism*
  • Hydrogels / therapeutic use*
  • Nanostructures / chemistry
  • Nanostructures / therapeutic use
  • Neoplasms / diagnosis
  • Neoplasms / metabolism
  • Neoplasms / therapy*
  • Precision Medicine / methods
  • Small Molecule Libraries / chemistry
  • Small Molecule Libraries / metabolism*
  • Small Molecule Libraries / therapeutic use*
  • Substrate Specificity
  • Theranostic Nanomedicine / methods*

Substances

  • Adjuvants, Immunologic
  • Hydrogels
  • Small Molecule Libraries